The News Review:

- CNRAD receives $28.5M Gates Foundation grant for HIV prevention…
- CUBA: SCRPIN VENM MAY FIGHT CANCER SCIENTISTS SAY.
- RAHC research center and veterans clinic dedicated
- Accutest Lab expands Ahmedabad clinical research operations
- Sweden: A European leader in life sciences
- Banned Scientist Now Works At Schering-Plough

CNRAD receives $28.5M Gates Foundation grant for HIV prevention…
eurekalert.org – Nov 30, 2007
” Microbicides are topical substances used intravaginally to potentially prevent HIV infection. Effective microbicides could be an important HIV prevention option for women who account for approximately half of all people living with HIV globally. New microbicide candidates CNRAD is currently researching contain several ingredients with different types of activity against HIV. Gabelnick continued “Due to the multiple pathways involved in mucosal infection and the number of new infections attributable to viruses that contain drug resistance-associated mutations development of a combination microbicide is likely to be important to achieve successful prevention of sexual transmission of HIV. “The microbicide field has accumulated a wealth of experience and understanding that is critical for accelerating progress toward an effective microbicide” said Dr.

CUBA: SCRPIN VENM MAY FIGHT CANCER SCIENTISTS SAY.
Free with registration – Inter Press Service – AccessMyLibrary.com – Nov 30, 2007
“We are concluding the studies of pre-clinical research in order to obtain registration and approval from Cuba’s regulatory entities to begin clinical trials on humans” said microbiologist Alexis D az the chief of the research team at Labiofam a biological pharmaceutical laboratory. The company is heading. CPYRIGHT 2007 Global Information Network.

RAHC research center and veterans clinic dedicated
Brownsville Herald – Nov 30, 2007
Researchers announced last month that Hidalgo County will be one of 100 sites nationwide participating in the children’s study which will follow 1000 local children from before birth until their 21st birthdays. The investigators will gather data on the impact of a variety of factors from diet to water quality to poverty on a child’s health and development. Some of the clinical research for that study will take place in Harlingen while genetics and statistics research will take place at the RAHC medical research building in Edinburg Vela said. The research facility in Edinburg is used for laboratory research genetics research and animal-based studies Vela said. The new Harlingen building will be used for studies involving human subjects he said. The presence of these research facilities will help to bring more medical residents to programs at the RAHC and set the stage for more doctors to practice here officials said. “(The RAHC) is developing a reputation as a top-notch facility” said Sen.

Accutest Lab expands Ahmedabad clinical research operations
Express Pharma – Nov 30, 2007
Accutest has clients from India as well as US Europe South Africa and Japan on its board. Dr Nirav Gandhi Vice-President Accutest says "Accutest has been functioning at Ahmedabad since 2005. Within a short span of two years it has expanded to its independent new facility at Ahmedabad. Accutest Ahmedabad will function as an independent CR with a state-of-the-art analytical lab in-house pathology lab quality assurance regulatory affairs and quality compliance documentation and report preparation.

Sweden: A European leader in life sciences
Express Pharma – Nov 30, 2007
Firms cover the entire value chain with particular strengths in drug discovery and development medical engineering and biopharmaceutical production Focus on translational and interdisciplinary research With more than 40000 employees and over 800 companies Sweden’s life science industry is one of Europe’s finest. A century-long tradition in medical research and development has laid the foundation to the current successes and efforts. Swedish research has long since emphasized the need to be close to patients and basic research activities are often integrated with clinical research a major advantage in the development of new therapies and treatments. Research objectives are often approached holistically by bringing together a wide range of disciplines and expertise to solve complex problems. Excellence in major research and industry fields Sweden’s strengths cover a surprisingly large share of the relevant biotech fields given its nine million population. A survey comparing biomedical research productivity in the US and European Union places Sweden first in four out of five categories measuring citations and publications in relation to population and R&D expenditure.

Banned Scientist Now Works At Schering-Plough
Pharmalot – Nov 30, 2007
All of the senior execs at Schering-Plough specialize in cheating without getting caught or being held responsible for their misdeeds. If they had to take a lie detector test in order to remain there the top two or three layers of mismanagement would have to goMDBDecember 2nd 20078:49 pm Link to this comment I agree. He’ll simply be like all the rest of the peas in the Schering-Plough pod!!!!ol crankyDecember 3rd 20072:13 pm Link to this comment Why is this surprising to anyone? Big pharma gets away with a lot of this crap! Back in 1999 rtho-McNeil hired Andrew Friedman someone who was barred from conducting research for 3 years and temporarily lost his license for committing research fraud as a Director of Clinical Research. He was promoted to senior director and was one of the guys who was trotted out to the media to assure of of the safety of ortho-evra and I don’t recall mainstream media pointing out his questionable history regarding data or the logic of rtho-McNeil hiring someone with that background to lead clinical research. GeorgeDecember 3rd 20072:56 pm Link to this comment This is a total railroad case by the Seattle Times. Seems they didn’t get much for spending legal money for this story. Think about it the University of Washington spent 16 months this guys info.